Maravai LifeSciences Holdings Inc (MRVI)
7.835
+0.06
(+0.84%)
USD |
NASDAQ |
Nov 05, 14:42
Maravai LifeSciences Holdings Gross Profit Margin (Quarterly): 47.86% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 47.86% |
| March 31, 2024 | 40.27% |
| December 31, 2023 | 52.65% |
| September 30, 2023 | 45.13% |
| June 30, 2023 | 37.21% |
| March 31, 2023 | 57.39% |
| December 31, 2022 | 73.99% |
| September 30, 2022 | 80.04% |
| June 30, 2022 | 84.55% |
| March 31, 2022 | 83.61% |
| Date | Value |
|---|---|
| December 31, 2021 | 82.87% |
| September 30, 2021 | 84.27% |
| June 30, 2021 | 82.64% |
| March 31, 2021 | 78.82% |
| December 31, 2020 | 76.21% |
| September 30, 2020 | 77.51% |
| June 30, 2020 | 54.81% |
| March 31, 2020 | 69.99% |
| December 31, 2019 | 50.42% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
37.21%
Minimum
Jun 2023
84.55%
Maximum
Jun 2022
66.33%
Average
73.99%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
| Repligen Corp | 49.82% |
| Evoke Pharma Inc | 98.37% |
| Personalis Inc | 35.59% |
| Tempus AI Inc | 45.50% |
| Codexis Inc | 66.36% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.98% |
| Return on Assets | -7.41% |
| Return on Invested Capital | -9.78% |
| Profit Margin (Quarterly) | -10.33% |
| Operating Margin (Quarterly) | -14.59% |
| Return on Net Operating Assets | -9.36% |